Publications by authors named "Gen Takayanagi"

Claim this Profile
P
Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise.
Linong Ji, Jianhua Ma, Weiping Lu, Jingdong Liu, Jiao'e Zeng, Gen Takayanagi

J Diabetes Investig· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of teneligliptin added to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled with metformin: A phase 3, randomized, double-blind, placebo-controlled study.
Linong Ji, Ling Li, Jianhua Ma, Xuefeng Li, Dongmei Li, Gen Takayanagi

Endocrinol Diabetes Metab· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mGluR1 antagonist decreases tyrosine phosphorylation of NMDA receptor and attenuates infarct size after transient focal cerebral ischemia.
Kazutoshi Murotomi, Norio Takagi, Gen Takayanagi, Megumi Ono, Satoshi Takeo

J Neurochem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis